Compare GOSS & KELYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GOSS | KELYB |
|---|---|---|
| Founded | 2015 | 1946 |
| Country | United States | United States |
| Employees | N/A | 5570 |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 615.7M | 513.9M |
| IPO Year | 2018 | N/A |
| Metric | GOSS | KELYB |
|---|---|---|
| Price | $0.42 | $16.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $8.83 | N/A |
| AVG Volume (30 Days) | ★ 16.9M | 109.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.30% |
| EPS Growth | ★ 78.81 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $114,701,000.00 | N/A |
| Revenue This Year | N/A | $0.72 |
| Revenue Next Year | $6.41 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.33 | $8.38 |
| 52 Week High | $3.87 | $125.00 |
| Indicator | GOSS | KELYB |
|---|---|---|
| Relative Strength Index (RSI) | 13.82 | 47.04 |
| Support Level | N/A | N/A |
| Resistance Level | $1.31 | $16.33 |
| Average True Range (ATR) | 0.17 | 9.58 |
| MACD | -0.18 | -0.80 |
| Stochastic Oscillator | 1.65 | 1.92 |
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services to a diverse group of clients operating in the Americas, Europe, and the Asia-Pacific region across various industries. The company's reportable segments are: Enterprise Talent Management, Science, Engineering and Technology, and Education. Maximum revenue is generated from its Enterprise Talent Management segment, which delivers temporary staffing, outcome-based, and permanent placement services focused on light industrial, contact center, and office and clerical specialties in North America across various industries. It also provides talent supply chain and workforce talent solutions, including MSP, RPO, and PPO solutions to its clients. Geographically, it derives key revenue from the USA.